These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16601678)

  • 1. Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2.
    Gresko E; Roscic A; Ritterhoff S; Vichalkovski A; del Sal G; Schmitz ML
    EMBO J; 2006 May; 25(9):1883-94. PubMed ID: 16601678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
    Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
    Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
    J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.
    Nardinocchi L; Puca R; Sacchi A; D'Orazi G
    Mol Cancer; 2009 Jan; 8():1. PubMed ID: 19128456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
    Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
    Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1.
    Choi DW; Seo YM; Kim EA; Sung KS; Ahn JW; Park SJ; Lee SR; Choi CY
    J Biol Chem; 2008 Feb; 283(8):4682-9. PubMed ID: 18093972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How cells switch HIPK2 on and off.
    Sombroek D; Hofmann TG
    Cell Death Differ; 2009 Feb; 16(2):187-94. PubMed ID: 18974774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
    D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
    Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis.
    Di Stefano V; Rinaldo C; Sacchi A; Soddu S; D'Orazi G
    Exp Cell Res; 2004 Feb; 293(2):311-20. PubMed ID: 14729469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage.
    Lazzari C; Prodosmo A; Siepi F; Rinaldo C; Galli F; Gentileschi M; Bartolazzi A; Costanzo A; Sacchi A; Guerrini L; Soddu S
    Oncogene; 2011 Dec; 30(48):4802-13. PubMed ID: 21602882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
    Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
    Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
    Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
    FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function.
    Di Stefano V; Blandino G; Sacchi A; Soddu S; D'Orazi G
    Oncogene; 2004 Jul; 23(30):5185-92. PubMed ID: 15122315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.
    Polonio-Vallon T; Kirkpatrick J; Krijgsveld J; Hofmann TG
    Cell Cycle; 2014; 13(1):115-25. PubMed ID: 24196445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
    Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
    Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between Mdm2 and HIPK2 in the DNA damage response.
    Zhang XP; Liu F; Wang W
    J R Soc Interface; 2014 Jul; 11(96):. PubMed ID: 24829283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
    Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
    Nardinocchi L; Puca R; Givol D; D'Orazi G
    FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.